The process of antibody lead generation, optimization, and production is often labor intensive and risky. If you are developing a therapeutic Ab, do you humanize after selecting an antibody, or start with a humanized antibody? Selecting the right experimental approach early on is a critical step in successfully identifying and developing the right protein/antibody lead candidate.

Join us for lunch to learn about important considerations at each step of the antibody discovery process. This lunch is sponsored and hosted by GenScript Probio. 

• Dr. Lan Tang is the Director of Scientific Solution at GenScript Probio, providing presales consultation on antibody drug discovery, development, process development, and GMP/GMP compliance plasmid and virus services. Lan has 26 years biomedical experiences, with diverse background in academic, hospital, and biotech industries. She holds a medical degree from China, and obtained her Ph.D degree from Carnegie Mellon University. She also had her Postdoc experience in Yale Medical school.

Agenda:

• 12:00-1:00PM – Lunch